Eli Lilly Stock (LLY) Holds Near $1,078 After Friday’s Close as GLP‑1 Pricing, Pill Competition, and Retatrutide Data Shape the 2026 Outlook
New York — As of 7:56 p.m. ET on Friday, December 26, 2025, Eli Lilly and Company (NYSE: LLY) is coming off a session that left the stock hovering around $1,077.75, essentially flat on the day after a narrow trading range. With U.S. markets now shut for the weekend, the next major read for investors will come when trading resumes Monday—against a backdrop of fast-moving headlines in obesity drugs, shifting reimbursement and pricing policy, and fresh late‑stage pipeline data that continues to redefine what “best‑in‑class” can mean in metabolic medicine. LLY stock check: where Eli Lilly finished Friday and what